Skip to content

Clinical trials

Completed Lung Diseases, Interstitial trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Completed Country / region: Germany Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20123
20133
20142
20151
20173
20193
20201
20211
20226
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim8
Schön Klinik Berchtesgadener Land3
Insmed Incorporated2
Wissenschaftliches Institut Bethanien e.V2
Actelion1
Biogen1
Bristol-Myers Squibb1
Heidelberg University1
Hoffmann-La Roche1
Klaus Kenn1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial26
Idiopathic Pulmonary Fibrosis5
Pulmonary Disease, Chronic Obstructive5
Hypertension, Pulmonary3
Dyspnea2
Idiopathic Interstitial Pneumonias2
Lung Diseases2
Neoplasms2
Pulmonary Fibrosis2
Sarcoidosis2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.